Hasan Jilaihawi, MD, MRCP, CCT (UK)
Director, Interventional Cardiology Imaging
Hasan Jilaihawi, MD, is an Interventional Cardiologist and the Director of Interventional Cardiology Imaging at Cedars-Sinai Heart Institute. He is involved in all aspects of cardiology, with a special interest in innovative methods of imaging the heart, complex percutaneous coronary intervention and device and patient selection within the novel field of transcatheter aortic valve replacement (TAVR). His international reputation in the field has earned him the prestigious responsibility of running the CT corelab for the pivotal US trial of the Portico device, the world’s first fully repositionable and retrievable TAVR, as well as the CT corelab for China’s first TAVR trial.
Raised from childhood in the UK, Dr. Jilaihawi graduated from the University of Edinburgh with Honors. He has completed the highest standard of clinical training in several nations world-wide, including Scotland (Royal Infirmary of Edinburgh), England (Barts and The Royal London Hospital and University Hospitals of Leicester), the USA (Harvard Medical School), France (Clinique Pasteur, Toulouse) and Canada (Montreal Heart Institute). Following this global experience, Dr. Jilaihawi completed an advanced interventional cardiology fellowship at Cedars-Sinai Medical Center, accredited by UCLA School of Medicine. Eloquent in English, French and Arabic, Dr. Jilaihawi’s trans-Atlantic experience is unique in that he is one of only a handful of physicians in the world to complete full interventional cardiology training for two continents (North America and Europe).
Dr. Jilaihawi has a strong foundation in clinical research, having authored over 70 publications and several book chapters in his field, as well as being a speaker at countless international meetings and an active reviewer for several high-profile journals, including the Journal of the American College of Cardiology and the European Heart Journal. Notably, his research into advanced imaging for TAVR changed international practice for procedural planning. The adoption of Dr. Jilaihawi’s methodology at Cedars-Sinai contributed to the extremely low 30-day mortality for transfemoral TAVR. Driven by applying clinical research directly to patient care, at below 1%, Cedars-Sinai now holds one of the lowest 30-day mortality rates for this procedure world-wide. Dr. Jilaihawi is passionate about pushing forward such clinically important research and has designed numerous international research collaborations, including a study for TAVR in bicuspid aortic stenosis and a multi-centric study on the use of state-of-the-art imaging to guide TAVR procedural planning.
Dr. Jilaihawi maintains a keen interest in bringing promising new technologies to meet the unmet clinical needs of patients worldwide. In 2007, he was one of the two doctors who performed the UK's first TAVR procedure, as well as being the key clinical advisor for the world’s first successful transcatheter pulmonary valve replacement procedure with a self-expanding device, performed in Vietnam in 2011. Dr. Jilaihawi also serves as an investigator for numerous US next generation TAVR device trials, including Portico (St. Jude), Corevalve (Medtronic) and Sapien-3 (Edwards Lifesciences).
Beyond his active research and clinical activities, Dr. Jilaihawi is a prolific innovator. From Belgium, the world’s largest 3-D printing company has collaborated with him in order to explore interventional applications for its technology. Dr. Jilaihawi was one of the first physicians in the world to apply 3-D printing to create true-to-life models of patient hearts for both procedural planning and to increase patient understanding of TAVR. Similarly, he is working with software engineers in the Netherlands to develop algorithms for mainstream use that can help simplify and standardize optimal TAVR case selection. Following in the great tradition of discovery at Cedars-Sinai, as well as exploiting all available imaging techniques and new technologies in his practice, Dr. Jilaihawi has invented several of his own cardiac devices, in partnership with Cedars-Sinai Medical Center.
Dr. Jilaihawi is a caring and compassionate physician and has the highest regard for patient comfort. He is well known at Cedars-Sinai for his kind and thoughtful bedside manner, his meticulous attention to detail and for the time he spends to ensure medical complexities are well understood by both patients and families.